profile-img
Mark Yarchoan

@MarkYarchoan

Physician scientist @JohnsHopkins @hopkinskimmel, focused on translational immunotherapy research for #HCC, #cholangiocarcinoma

calendar_today03-03-2018 23:07:02

453 Tweets

1,5K Followers

353 Following

Mark Yarchoan(@MarkYarchoan) 's Twitter Profile Photo
Mark Yarchoan
@MarkYarchoan

5 months ago

IPI+NIVO after prior PD1/L1 in HCC?
➡️Retrospective series, half tx w/ prior BEV/ATEZO (no prior anti-CTLA4)
➡️ORR 22% (7/32)
➡️All responders to late line IPI+NIVO had NONRESPONSE to prior PD1/L1
ncbi.nlm.nih.gov/pmc/articles/P…

IPI+NIVO after prior PD1/L1 in HCC? ➡️Retrospective series, half tx w/ prior BEV/ATEZO (no prior anti-CTLA4) ➡️ORR 22% (7/32) ➡️All responders to late line IPI+NIVO had NONRESPONSE to prior PD1/L1 ncbi.nlm.nih.gov/pmc/articles/P…
account_circle